Psy83 - Impact of Dose Escalation on Average Cost and Cost-Effectiveness of Anti-TNF and Ustekinumab in the Treatment of Moderate-To-Severe Plaque Psoriasis in Sweden
Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.2658
Full Text
Open PDFAbstract
Available in full text
Date
October 1, 2018
Authors
Publisher
Elsevier BV